Concert Pharmaceuticals, Inc. (CNCE): Price and Financial Metrics
CNCE Price/Volume Stats
| Current price | $8.37 | 52-week high | $8.55 |
| Prev. close | $8.36 | 52-week low | $2.66 |
| Day low | $8.35 | Volume | 10,733,200 |
| Day high | $8.55 | Avg. volume | 2,970,800 |
| 50-day MA | $7.49 | Dividend yield | N/A |
| 200-day MA | $5.99 | Market Cap | 401.24M |
CNCE Stock Price Chart Interactive Chart >
Concert Pharmaceuticals, Inc. (CNCE) Company Bio
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform (deuterated chemical entity platform) to create novel small molecule drugs. The company was founded in 2006 and is based in Lexington, Massachusetts.
CNCE Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CNCE Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 70.47% |
| 5-year | -10.86% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | 85.40% |
| 2021 | -75.08% |
| 2020 | 37.02% |